Atea Pharmaceuticals Inc (AVIR) — Financial Flexibility Index
Atea Pharmaceuticals Inc (AVIR) has a Financial Flexibility Index of -1.32x as of June 2026. Free cash flow of $-37.08 Million (operating CF $-37.08 Million minus capex $0.00) represents -1% of total liabilities ($28.12 Million). Check AVIR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Atea Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Atea Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Atea Pharmaceuticals Inc cash conversion from operations.
Annual Financial Flexibility Index for Atea Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Atea Pharmaceuticals Inc. Explore AVIR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.32x | $-132.03 Million | $-132.03 Million | $39.78 Million | ▲ +36.8% |
| 2024 | -5.25x | $-135.50 Million | $-135.50 Million | $25.80 Million | ▼ -144.6% |
| 2023 | -2.15x | $-85.39 Million | $-85.39 Million | $39.78 Million | ▲ +52.9% |
| 2022 | -4.55x | $-119.04 Million | $-120.98 Million | $26.14 Million | ▼ -228.8% |
| 2021 | -1.39x | $-87.00 Million | $-87.00 Million | $62.81 Million | ▼ -247.4% |
| 2020 | 0.94x | $296.76 Million | $296.73 Million | $315.83 Million | ▲ +625.4% |
| 2019 | -0.18x | $-12.81 Million | $-12.81 Million | $71.64 Million | ▼ -60.9% |
| 2018 | -0.11x | $-7.90 Million | $-7.91 Million | $71.02 Million | — |